Protection from Bb Rat Diabetes by the Platelet-Activating Factor Inhibitor BN50730

References

• Hosford D, Michell J, Braquet P. Platelet-activating factor (PAF) and PAF antagonists in asthma. Critical Reviews in Therapeutic Drug Carrier Sysrtems 1990; 7: 261–273
   PubMed Web of Science ®Google Scholar
• Braquet P, Rola-Pleszczynski M. Platelet-activating factor and cellular immune responses. Imm. Today 1987; 8: 345–352
   PubMedGoogle Scholar
• Rola-Pleszczynski M. PAF in cellular immunology. Prog. biochem. Pharmacol. 1988; 22: 81–89
   Google Scholar
• Wardlaw AJ, Moqbel T, Cromwell O, Kay AB. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J Clin. Invest. 1986; 78: 1701–1706
   PubMed Web of Science ®Google Scholar
• Rola-Pleszczynski M, Pignol B, Pouliot C, Braquet P. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether):reversal by a specific antagonist, BN52021. Biochem. Biophys. Res. Commun. 1987; 142: 754–760
   Google Scholar
• Rola-Pleszczynski M, Pouliot C, Turcotte S, Pignol B, Braquet P, Bouvrette L. Immune regulation by platelet-activating factor: induction of suppressor cell activity in human monocytes and CD8 + T cells and of helper cell activity in CD4+ T cells. Journal of Immunology 1988; 140: 3547–3552
   Google Scholar
• Rola-Pleszczynski M, Pouliot C, Pignol B, Braquet P. Platelet activating factor induces human suppressor cell activity. Fed. Proc. 1987; 46: 743
   Google Scholar
• Mandi Y, Farkas G, Koltai M, Beladi I, Braquet P. Effect of the platelet-activating factor antagonist BN52021 on human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 1989; 88: 222–224
   Google Scholar
• Lee KU, Kim MK, Amano K, Pak CY, Jaworski MA, Mehta JG, Yoon J-W. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 1988; 37: 1053–1058
   PubMed Web of Science ®Google Scholar
• Crisa L, Mordes JP, Rossin AA. Autoimmune diabetes mellitus in the BB rat. Diabetes/Metab Rev 1992; 8: 9–37
   Google Scholar
• Baekkeskov S, Dyrberg T, Lernmark Å. Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 1984; 224: 1348–1350
   PubMed Web of Science ®Google Scholar
• Seemayer T, Tannenbaum G, Goldman H, Colle E. Dynamic time course studies in the spontaneously diabetic BB Wistar rat. III. Light-microscopic and ultrastructural observations of pancreatic islets of Langerhans. Am J. Path. 1982; 106: 237–250
   PubMed Web of Science ®Google Scholar
• Logothetopoulos J, Valiquette N, Madura E, Cvet D. The onset of the progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy. Diabetes 1984; 33: 33–36
   PubMed Web of Science ®Google Scholar
• Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 1989; 32: 126–134
   PubMed Web of Science ®Google Scholar
• Dean BM, Walker R, Bone AJ, Baird JD, Cooke A. Prediabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Beck JC, Goodner CJ, Wilson C, Wilson D, Glidden D, Baskin DG, Lernmark Å, Braquet P. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. Autoimmunity 1991; 9: 225–235
   PubMedGoogle Scholar
• Markholst H, Andreasen B, Eastman S, Lernmark Å. Diabetes segregates as a single locus in crosses between imbred BB rats prone or resistant to diabetes. J. Exp. Med. 1991; 174: 297–300
   PubMed Web of Science ®Google Scholar
• Kohler E, Varnai G, Knospe S, Michaelis D, Wanka H. Effects of the platelet-activating factor antagonist BN52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients. Int. Arch. Allergy Appl. Immunol. 1991; 95: 352–355
   Google Scholar
• Ginkgolides -chemistry, biology, pharmacology and clinical perspectives. Prous Science Publishers. Graft protective effect of BN 52021, P. Braquet, J R. Barcelona, G Farkas, Y Mandi, M Koltai, P. Braquet. A specific PAF-acether antagonist in an in vitro langerhans islet-splenic lymphocyte model;. 1988; 737–741
   Google Scholar
• Nicoletti F, Meroni PL, Landolfo S, Gariglio M, Guzzardi S, Barcellini W, Lunetta M, Mughini L, Zanussi C. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ. Lanced 1990; 336: 319
   PubMedGoogle Scholar
• Satoh J, Seino H, Shintani S, Tanaka S-I, Ohteki T, Masuda T, Nobunaga T, Toyota T. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-α. Journal of Immunology 1990; 145: 1395–1399
   PubMed Web of Science ®Google Scholar
• Wilson CA, Jacobs C, Baker P, Baskin DG, Dower S, Lernmark A, Toivola B, Vertrees S, Wilson D. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 1990; 144: 3784–3788
   PubMed Web of Science ®Google Scholar
• Vertrees S, Wilson CA, Ubungen R, Wilson D, Baskin DG, Toivola B, Jacobs C, Boiani N, Baker P, Lernmark A. Interleukin-β regulation of islet and thyroid autoimmunity in the BB rat. J. Autoimmunity 1991; 4: 717–732
   Google Scholar
• Pignol B, Henane S, Sorlin BB, Rola-Pleszczynski M, Mencia-Huerta J, Braquet P. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells. J. Immunol 1990; 145: 980–984
   Google Scholar
• Sobel DO, Newsome J, Ewel CH, Bellanti JA, Abbassi V, Creswell K, Blair O. Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 1992; 515–520
   Google Scholar
• Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM. Induction of type 1 diabetes by Kilham's rat virus in diabetes-resistant BB wor rats. Science 1991; 254: 1010–1013
   PubMed Web of Science ®Google Scholar